Aspire Biopharma Holdings, Inc. Common Stock

ASBPNASDAQ • USD
ThemeNanotech & Adv. Materials›Nanomedicine & Drug Delivery
6.46 USD
↘ 0.09 (1.30%)AT CLOSE (11:59 AM EDT)
6.20
↘ 0.26 (4.01%)
POST MARKET (AS OF 07:51 PM EDT)
Post Market
AS OF 07:51 PM EDT
6.20
↘ 0.26 (4.01%)
🔴Market: CLOSED

Aspire Biopharma Holdings, Inc. Common Stock (ASBP) is currently trading at $6.35. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. ASBP is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jun 25, 2026.

Open?$6.48
High?$6.59
Low?$6.19
Prev. Close?$6.54
Volume?70.7K
Avg. Volume?760.0K
VWAP?$6.39
Rel. Volume?0.09x
Bid / Ask
Bid?$3.72 × 200
Ask?$6.60 × 500
Spread?$2.88
Midpoint?$5.16
Valuation & Ratios
Market Cap?8.4M
Shares Out?1.3M
Float?4.5M
Float %?89.7%
P/E Ratio?N/A
P/B Ratio?2.16
EPS?-$9.08
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
Themes
Nanotechnology & Advanced Materials›Nanomedicine & Drug DeliveryBiotech - Drug Development›Clinical-Stage Platforms
Employees
N/A
Market Cap
8.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.aspirebiolabs.com
Listed
2025-02-20
Address
23150 FASHION DRIVE, SUITE 232
ESTERO, FL 33928
Phone: 561-704-8527
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
69
Short Sent.?
63
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.30Distress
Confidence?40%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?7.50%Elevated
Short Interest?337.9K
Days to Cover?1.0
Free Float4.5M
Avg Daily Volume1.2M
Settlement Date2026-06-15
Financial Health
Current Ratio?2.26Strong
Quick Ratio?2.14Strong
Cash Ratio?1.86Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
71
2.16CHEAP▾
P/S?
Peers
100
S&P
3
242.14HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.5CHEAP▾
EV/Sales?
Peers
100
S&P
3
72.64HIGH▾
Returns & Efficiency
ROE?
S&P
3
-304.1%WEAK▾
ROA?
S&P
3
-165.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$2.5M
Fundamentals ratios updated end of day
MarketsMoversWatchlist